[1] |
Hou W, Zhou B, Hou G, et al. Small cell neuroendocrine carcinoma expressing alpha fetoprotein in the endometrium[J]. Open Life Sci, 2021, 16(1):1219-1224. doi: 10.1515/biol-2021-0122.
pmid: 34805530
|
[2] |
Pang L, Yang H, Ning Y, et al. Retrospective Analysis of Clinicopathological Features and Prognosis of Gynecological Small-Cell Carcinoma[J]. Cancer Manag Res, 2021, 13:4529-4540. doi: 10.2147/CMAR.S314686.
pmid: 34135630
|
[3] |
Zhang J, Pang L. Primary Neuroendocrine Tumors of the Endometrium: Management and Outcomes[J]. Front Oncol, 2022, 12:921615. doi: 10.3389/fonc.2022.921615.
|
[4] |
刘玉芬, 佟丽波, 邢天容, 等. 原发性子宫内膜小细胞神经内分泌癌1例并文献复习[J]. 实用妇科内分泌电子杂志, 2019, 6(16):195-196. doi: 10.16484/j.cnki.issn2095-8803.2019.16.141.
|
[5] |
Iida T, Muramatsu T, Kajiwara H, et al. Small Cell Neuroendocrine Carcinoma of the Endometrium with Difficulty Identifying the Original Site in the Uterus[J]. Tokai J Exp Clin Med, 2020, 45(4):156-161.
pmid: 33300584
|
[6] |
Kitajima K, Kihara T, Kawanaka Y, et al. Characteristics of MR Imaging for Staging and Survival Analysis of Neuroendocrine Carcinoma of the Endometrium: A Multicenter Study in Japan[J]. Magn Reson Med Sci, 2021, 20(3):236-244. doi: 10.2463/mrms.mp.2020-0056.
|
[7] |
Ebisu Y, Ishida M, Okano K, et al. Small-cell neuroendocrine carcinoma in directly sampled endometrial cytology: A monocentric retrospective study of six cases[J]. Diagn Cytopathol, 2019, 47(12):1297-1301. doi: 10.1002/dc.24298.
pmid: 31386298
|
[8] |
Akgor U, Kuru O, Sakinci M, et al. Neuroendocrine carcinoma of the endometrium: A very rare gynecologic malignancy[J]. J Gynecol Obstet Hum Reprod, 2021, 50(5):101897. doi: 10.1016/j.jogoh.2020.101897.
|
[9] |
Matsumoto H, Shimokawa M, Nasu K, et al. Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan[J]. J Gynecol Oncol, 2019, 30(6):e103. doi: 10.3802/jgo.2019.30.e103.
|
[10] |
Korcum AF, Aksu G, Ozdogan M, et al. StageⅠsmall cell carcinoma of the endometrium: survival and management options[J]. Acta Obstet Gynecol Scand, 2008, 87(1):122-126. doi: 10.1080/00016340701709307.
|
[11] |
谷莹莹, 任晓蕾, 刘一, 等. 贝伐珠单抗临床应用评价及肾脏不良反应分析[J]. 临床药物治疗杂志, 2023, 21(12):80-84. doi: 10.3969/j.issn.1672-3384.2023.12.015.
|
[12] |
Frumovitz M, Munsell MF, Burzawa JK, et al. Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix[J]. Gynecol Oncol, 2017, 144(1):46-50. doi: 10.1016/j.ygyno.2016.10.040.
pmid: 27823771
|